Fuji Pharma Co. Ltd.

Industry

  • Pharmaceuticals
    • Vaccines
    • Generic Drugs
    • Nutraceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Distributors
See more in Biomedtracker

Latest on Fuji Pharma Co. Ltd.

Pink Sheet

Mecobalamin For ALS Among New Japan Recommendations

 
• By Lisa Takagi

An advisory committee to Japan’s Ministry of Health, Labour and Welfare (MHLW) has recommended the approval of eight new drugs, including a global-first indication for Eisai Co., Ltd. ’s ultra-high d

Scrip

Finance Watch: Public Companies Pursue All Options To Fund R&D, Launches

 
• By Mandy Jackson

The usual pattern of reporting positive clinical trial results or winning US Food and Drug Administration approval then launching a large follow-on public offering (FOPO) has become less common under

Scrip

Asia Deal Watch: US Biotech LIB Partners In Greater China With Hasten On PCSK9 Therapy

 
• By Joseph Haas, Jung Won Shin, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Hasten Gets Greater China Rights T

Scrip

Asia Deal Watch: Astellas Begins 2023 Signing Rare Disease Tie-Ups With Selecta, Twist

 
• By Joseph Haas, Ian Haydock, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Taps Selecta For Gene The